NASDAQ · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS · MID CAP
MediWound Ltd. MDWD
11 fiscal years on record · USD · FY2025 reported · SEC filings only
Growth
USD 17.0M
Revenue, FY2025 · full 11-year series below
Revenue $M
Net income $M
FY2025 · Revenue 17.0 · Net income -23.9
Compound annual growth
Revenue compounded at −4.9% a year over five years.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−141 cents
lost on every revenue dollar
Operating margin
Net margin
FY2025 · Operating -149.0% · Net -140.8%
ROE
Not available in our data for this period.
The 11-year record
11 fiscal years
Every figure from documents filed with the SEC · USD
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating income $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| EBITDA $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| Income tax $B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | · |
| Net income $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| Free cash flow $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| EPS, diluted $ | −2.10 | −3.03 | −0.75 | −3.93 | −3.48 | −2.38 | · | · | · | · | · |
| Dividend / sh $ | · | · | · | · | · | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · | · | · | · | · | · |
| ROE % | · | · | · | · | · | · | · | · | · | · | · |
| Shares out B | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Compare
This company against its peers
MediWound Ltd.vsCuraleaf Holdings, Inc.Same industry: Medicinal Chemicals & Botanical ProductsMediWound Ltd.vsTrulieve Cannabis Corp.Same industry: Medicinal Chemicals & Botanical ProductsMediWound Ltd.vsTilray Brands, Inc.Same industry: Medicinal Chemicals & Botanical ProductsMediWound Ltd.vsNiagen Bioscience, Inc.Same industry: Medicinal Chemicals & Botanical ProductsMediWound Ltd.vsUsana Health Sciences Inc.Same industry: Medicinal Chemicals & Botanical ProductsMediWound Ltd.vsbiote Corp.Same industry: Medicinal Chemicals & Botanical ProductsMediWound Ltd.vsCronos Group Inc.Same industry: Medicinal Chemicals & Botanical Products
Provenance
Company facts, as filed
How we verify · 0 failures in 47 reconciliationsAUDITED
Reconciled in 11 of 19 fiscal years. 48 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityMedicinal Chemicals & Botanical Products
Listed onNASDAQ
Incorporated inoutside the United States — SEC code L3
Fiscal year endsDecember 31
Data on record since2015